On October 16, 2018, Zosano Pharma Corporation announced that the company entered into an employment agreement with Greg Kitchener, age 47, in connection with the commencement of his employment with the Company as Chief Financial Officer, effective as of October 15, 2018. Since August 2015, Mr. Kitchener has served as the Chief Financial Officer of BioPharmX Corporation, a pharmaceutical company. Prior to joining BioPharmX, from July 2008 to July 2015, Mr. Kitchener served in roles of increasing responsibility at Cepheid Inc., a biotechnology company, including serving as Vice President of Finance from October 2011 to July 2015. Mr. Kitchener holds a B.A. from the University of California, Santa Cruz and an M.B.A. from Cornell University’s Johnson Graduate School of Management.